dextroamphetamine has been researched along with Nerve Degeneration in 15 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steindler, DA | 1 |
| Fredriksson, A | 1 |
| Archer, T | 1 |
| Ellison, G | 1 |
| Switzer, RC | 1 |
| Consolo, S | 1 |
| Baronio, P | 1 |
| Guidi, G | 1 |
| Di Chiara, G | 1 |
| Bowyer, JF | 2 |
| Peterson, SL | 1 |
| Rountree, RL | 1 |
| Tor-Agbidye, J | 1 |
| Wang, GJ | 1 |
| Natsume, A | 1 |
| Mata, M | 1 |
| Goss, J | 1 |
| Huang, S | 1 |
| Wolfe, D | 1 |
| Oligino, T | 1 |
| Glorioso, J | 1 |
| Fink, DJ | 1 |
| Reid, JL | 1 |
| Iversen, SD | 1 |
| Creese, I | 1 |
| Ryan, LJ | 3 |
| Linder, JC | 3 |
| Martone, ME | 3 |
| Groves, PM | 3 |
| Ziegler, MG | 1 |
| Szechtman, H | 1 |
| Warenycia, MW | 1 |
| McKenzie, GM | 1 |
| Murphy, M | 1 |
| Szerb, JC | 1 |
| Javoy, F | 1 |
| Agid, Y | 1 |
| Bouvet, D | 1 |
| Glowinski, J | 1 |
15 other studies available for dextroamphetamine and Nerve Degeneration
| Article | Year |
|---|---|
Neural stem cells, scaffolds, and chaperones.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biocompatible Materials; Cell Survival; Dextr | 2002 |
Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD.
Topics: Animals; Animals, Newborn; Apoptosis; Attention Deficit Disorder with Hyperactivity; Central Nervous | 2004 |
Dissimilar patterns of degeneration in brain following four different addictive stimulants.
Topics: Animals; Brain; Cocaine; Dextroamphetamine; Disease Models, Animal; Drug Implants; Methamphetamine; | 1993 |
Role of the parafascicular thalamic nucleus and N-methyl-D-aspartate transmission in the D1-dependent control of in vivo acetylcholine release in rat striatum.
Topics: Acetylcholine; Animals; Benzazepines; Dextroamphetamine; Dizocilpine Maleate; Dopamine Agonists; Dop | 1996 |
Neuronal degeneration in rat forebrain resulting from D-amphetamine-induced convulsions is dependent on seizure severity and age.
Topics: Age Factors; Animals; Basal Ganglia; Behavior, Animal; Body Temperature; Catecholamines; Dextroamphe | 1998 |
Neuronal degeneration in the limbic system of weanling rats exposed to saline, hyperthermia or d-amphetamine.
Topics: Animals; Caudate Nucleus; Central Nervous System Stimulants; Dextroamphetamine; Fever; Glial Fibrill | 2000 |
Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration.
Topics: Animals; beta-Galactosidase; Corpus Striatum; Dextroamphetamine; Dopamine; Female; Functional Latera | 2001 |
Dopamine supersensitivity in the hypothalamus?
Topics: Animals; Antiparkinson Agents; Body Temperature Regulation; Bromocriptine; Clonidine; Dextroamphetam | 1975 |
Behavioral correlates of dopaminergic supersensitivity.
Topics: Animals; Animals, Newborn; Apomorphine; Behavior; Brain Chemistry; Cerebral Cortex; Corpus Striatum; | 1975 |
Histological and ultrastructural evidence that D-amphetamine causes degeneration in neostriatum and frontal cortex of rats.
Topics: Animals; Arousal; Behavior, Animal; Brain; Cerebral Cortex; Corpus Striatum; Dextroamphetamine; Dose | 1990 |
Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system.
Topics: Animals; Apomorphine; Corpus Striatum; Dextroamphetamine; Dominance, Cerebral; Dopamine; Dose-Respon | 1990 |
The effects of cortical ablation on multiple unit activity in the striatum following dexamphetamine.
Topics: Animals; Behavior, Animal; Cerebral Cortex; Corpus Striatum; Dextroamphetamine; Electrophysiology; E | 1987 |
Continuous amphetamine administration induces tyrosine hydroxylase immunoreactive patches in the adult rat neostriatum.
Topics: Animals; Cocaine; Corpus Striatum; Dextroamphetamine; Enzyme Induction; Male; Nerve Degeneration; Ra | 1988 |
Cocaine, in contrast to D-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of Long-Evans rats.
Topics: Animals; Axons; Behavior, Animal; Cerebral Cortex; Cocaine; Corpus Striatum; Dextroamphetamine; Dopa | 1988 |
In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum.
Topics: Animals; Corpus Striatum; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Hydroxylation; Male; | 1974 |